Growth momentum Saluda Medical recently completed a public listing and has raised significant funding, signaling strong growth potential and readiness for scaled commercial expansion in the U S and international markets.

Advanced therapy The Evoke System delivers ECAP-controlled closed-loop SCS with real-time neural feedback, offering a differentiated value proposition that can be pitched to clinicians seeking more precise pain management and better patient outcomes.

US market entry Full commercial launch of EVA sensing technology in the United States creates a key entry point for cross-sell opportunities with Evoke SmartLoop systems and related neuromodulation products.

Clinical validation Ongoing clinical data presentations and awards at NANS 2025 provide talking points for key opinion leaders and can support rollout into hospitals and pain clinics with evidence of improved efficacy.

Strategic partnerships Significant funding and leadership change with a new CEO alongside a growing product suite indicate openness to partnerships, distributors, and collaboration with larger medical device players to accelerate market penetration.